METHODS FOR ASSESSING THE NEGATIVE IMPACT OF CANCER ON THE NATIONAL ECONOMY

The article is devoted to the research of methods for assessing of the negative impact of oncological diseases on the country's economy. It is established that the assessment of the economic burden of diseases is an important indicator for solving urgent problems in the field of health management, including justifying the costs of developing and implementing programs for screening and early diagnosis of malignant neoplasms and setting priorities for the development of the health system. The concept of "economic burden of the disease" is defined. The existing methods of assessing the negative impact of malignant neoplasms on the national economy are analyzed, including the disease cost method and the method assessing the impact of diseases on economic growth. The advantages and disadvantages of each of these methods are identified.

1. Winslow, C. E. (1951) The cost of sickness and the price of health. WHO Monograph Series. (7), 106.

2. Prokhorov, B. B. (1976) Medico-geographical approaches to the problems of optimizing the work and life of the population in the economic development of areas with harsh nature. Problemy razvitiya raionov s ekstremal'nymi prirodnymi usloviyami. 119-157. (In Russian).

3. Strumilin, S. G. (1966) On the national economic efficiency of healthcare. Ekonomicheskie nauki. (5), 29. (In Russian).

4. Troshina, I. M. [et al.] (1984) Raschet predotvrashchennogo ekonomicheskogo ushcherba pri vnedrenii v praktiku zdravoohraneniya novyh metodov lecheniya i obsledovaniya bol'nyh [Calculation of the prevented economic damage during the introduction of new methods of treatment and examination of patients into the practice of healthcare] Moscow, Min. zdravoohraneniya SSSR. (In Russian).

5. Kontsevaya, A. V. [et al.] (2011) Socio-economic damage from acute coronary syndrome in the Russian Federation. Racional'naya farmakoterapiya v kardiologii. 7 (2), 158-166. (In Russian).

6. Kamalova, F. M. [et al.] (2008) Economic damage due to temporary disability, disability and mortality in gastric cancer among people of working age. Gorodskoe zdravoohranenie. (5), 50-51. (In Russian).

7. Omelyanovsky, V. V. [et al.] (2011) Cost analysis of the disease – problems and solutions. Pediatricheskaya farmakologiya. 8 (3), 6-12. (In Russian).

8. Poddubnaya, I. V., Axel, E. M., Kupriyanova, N. S. (2007) Malignant neoplasms and their socio-economic consequences. Sibirskij onkologicheskij zhurnal. 3 (23), 64-68. (In Russian).

9. Potapchik, E. G., Popovich, L. D. (2013) Social'no-ekonomicheskaya effektivnost' gosudarstvennyh investiciĭ v medicinskie tekhnologii (na primere lecheniya otdel'nyh zabolevaniĭ kostno-myshechnoĭ sistemy i soedinitel'noĭ tkani) [Socio-economic efficiency of public investments in medical technologies (on the example of the treatment of certain diseases of the musculoskeletal system and connective tissue)] Moscow, Izd. dom Vysshei shkoly ekonomiki. (In Russian).

10. Leonov, S. A. [et al.] (2011). Assessment of economic losses of public health based on the global burden of disease Daly and cost effectiveness for all types of medical care using the QALY indicator. Menedzher zdravoohraneniya. (6), 14-28. (In Russian).